Literature DB >> 24176994

IDSA/ATS minor criteria aid pre-intensive care unit resuscitation in severe community-acquired pneumonia.

Hui Fang Lim1, Jason Phua, Amartya Mukhopadhyay, Wang Jee Ngerng, Mei Ying Chew, Tiong Beng Sim, Win Sen Kuan, Malcolm Mahadevan, Tow Keang Lim.   

Abstract

The effect of employing severity scores to identify severe community-acquired pneumonia (SCAP) cases for early aggressive resuscitation is unknown. Optimising pre-intensive care unit (ICU) care may improve outcomes in patients at risk of SCAP. We conducted a before-and-after study of patients classified into control and intervention groups (January 2004 to December 2007 and January 2008 to December 2010, respectively). Our intervention was two-pronged, using the 2007 Infectious Diseases Society of America (IDSA)/American Thoracic Society (ATS) minor criteria to identify SCAP for aggressive emergency department resuscitation. Patients with SCAP, defined as those with three or more IDSA/ATS minor criteria, were targeted. Differences in mortality, triage and compliance with emergency department resuscitation were compared between the groups. The hospital mortality rate was lower in the intervention versus the control group (5.7% versus 23.8%, p<0.001). On multivariate analysis, the intervention group was associated with lower mortality (OR 0.24, 95% CI 0.09-0.67). ICU admission rates decreased from 52.9% to 38.6% (p=0.008) and inappropriately delayed ICU admissions decreased from 32.0% to 14.8% (p<0.001). There was increased compliance with the aggressive resuscitation protocol after the intervention. A combined intervention, using a pneumonia score to identify those at risk of SCAP early and an aggressive pre-ICU resuscitation protocol may reduce mortality and ICU admissions.

Entities:  

Mesh:

Year:  2013        PMID: 24176994     DOI: 10.1183/09031936.00081713

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

1.  Community-Acquired Pneumonia in Adults.

Authors:  Martin Kolditz; Santiago Ewig
Journal:  Dtsch Arztebl Int       Date:  2017-12-08       Impact factor: 5.594

2.  In sepsis, beyond adherence, timeliness matters.

Authors:  Voon Shiong Ronnie Tan; Jason Phua; Tow Keang Lim
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 3.  Adjunct corticosteroid treatment in patients with pneumonia: A precision medicine approach.

Authors:  Srdjan Gavrilovic; Ana Andrijevic; Aida Mujakovic; Yewande Odeyemi; Belma Paralija; Ognjen Gajic
Journal:  Bosn J Basic Med Sci       Date:  2019-11-08       Impact factor: 3.363

4.  Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.

Authors:  Huriye Berk Takir; Antonio M Esquinas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-03-02

5.  Early identification of severe community-acquired pneumonia: a retrospective observational study.

Authors:  Frances S Grudzinska; Kerrie Aldridge; Sian Hughes; Peter Nightingale; Dhruv Parekh; Mansoor Bangash; Rachel Dancer; Jaimin Patel; Elizabeth Sapey; David R Thickett; Davinder P Dosanjh
Journal:  BMJ Open Respir Res       Date:  2019-06-05

6.  Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection.

Authors:  Phunsup Wongsurakiat; Napat Chitwarakorn
Journal:  BMC Pulm Med       Date:  2019-10-16       Impact factor: 3.317

7.  Modified IDSA/ATS Minor Criteria for Severe Community-Acquired Pneumonia Best Predicted Mortality.

Authors:  Hai-Yan Li; Qi Guo; Wei-Dong Song; Yi-Ping Zhou; Ming Li; Xiao-Ke Chen; Hui Liu; Hong-Lin Peng; Hai-Qiong Yu; Xia Chen; Nian Liu; Zhong-Dong Lü; Li-Hua Liang; Qing-Zhou Zhao; Mei Jiang
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

Review 8.  Severe community-acquired pneumonia: timely management measures in the first 24 hours.

Authors:  Jason Phua; Nathan C Dean; Qi Guo; Win Sen Kuan; Hui Fang Lim; Tow Keang Lim
Journal:  Crit Care       Date:  2016-08-28       Impact factor: 9.097

Review 9.  Advances in the prevention, management, and treatment of community-acquired pneumonia.

Authors:  Mathias W Pletz; Gernot G Rohde; Tobias Welte; Martin Kolditz; Sebastian Ott
Journal:  F1000Res       Date:  2016-03-08

10.  Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia.

Authors:  Sarah Berger; Cengiz Goekeri; Shishir K Gupta; Julio Vera; Kristina Dietert; Ulrike Behrendt; Jasmin Lienau; Sandra-Maria Wienhold; Achim D Gruber; Norbert Suttorp; Martin Witzenrath; Geraldine Nouailles
Journal:  Crit Care       Date:  2018-11-01       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.